HAVCR2 and neoplasm: Previous research has demonstrated that knocking out the HAVCR2 gene in dendritic cells significantly inhibits tumour growth and notably increases CD8+ T‐cell infiltration in tumours, encompassing early activated, effector, memory and memory precursor T cells, all of which play a crucial role in anti‐tumour immune responses [53].